Humacyte (HUMA) Equity Ratio (2020 - 2026)

Humacyte (HUMA) reported Equity Ratio of 0.11 for Q1 2026, down 52.58% year-over-year from 0.22 in Q1 2025, and up 293.53% quarter-over-quarter from 0.03 in Q4 2025.

Humacyte (HUMA) Equity Ratio (2020 - 2026) Analysis & Trends

Humacyte (HUMA) has 7 years of Equity Ratio data on file, last reported at 0.11 in Q1 2026.

  • Equity Ratio for Q1 2026 came in at 0.11, down 52.58% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.11 (down 52.58% YoY), and the FY2025 annual result was 0.03, up 106.99% from the prior year.
  • Equity Ratio climbed to 0.11 in Q1 2026 per HUMA's latest filing, from 0.03 in the prior quarter.
  • Over five years, Equity Ratio peaked at 0.58 in Q2 2022 and troughed at 0.56 in Q3 2024.
  • A 5-year average of 0.15 and a median of 0.16 in 2024 frame the typical range for Equity Ratio.
  • The sharpest annual moves came in 2022 and 2024: Equity Ratio jumped 115.28% in 2022, then sank 461.6% in 2024.
  • A 5-year view of Equity Ratio shows it stood at 0.57 in 2022, then slumped by 81.54% to 0.11 in 2023, then slumped by 461.6% to 0.38 in 2024, then soared by 106.99% to 0.03 in 2025, then surged by 293.53% to 0.11 in 2026.
  • Business Quant data shows HUMA's Equity Ratio at 0.11 in Q1 2026, 0.03 in Q4 2025, and 0.05 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Equity Ratio (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 191.07
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - 0.98
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - 0.04
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 0.58
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - 0.42
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 0.73
9 Abivax 94.26 Bn 94.26 Bn - 0.79
10 Humacyte 267.09 Mn 218.55 Mn -1.54 Mn 0.11

Historic Data

Download Data
DateValue
Mar 31, 2026 0.11
Dec 31, 2025 0.03
Sep 30, 2025 -0.05
Jun 30, 2025 0.03
Mar 31, 2025 0.22
Dec 31, 2024 -0.38
Sep 30, 2024 -0.56
Jun 30, 2024 -0.20
Mar 31, 2024 0.16
Dec 31, 2023 0.11
Sep 30, 2023 0.25
Jun 30, 2023 0.36
Mar 31, 2023 0.45
Dec 31, 2022 0.57
Sep 30, 2022 0.52
Jun 30, 2022 0.58
Mar 31, 2022 0.39
Dec 31, 2021 0.43
Sep 30, 2021 0.25
Jun 30, 2021 -3.78